open access
The decongestive lymphatic therapy in the massive primary lower limb lymphedema treatment
Affiliations- Division of Angiology, Wroclaw Medical University, Poland
- Department of Internal Medicine, 4th Military Hospital, Wroclaw, Poland
open access
Abstract
The decongestive lymphatic therapy is recommended by the International Society of Lymphology, the International Union of Phlebology and the International Lymphoedema Framework as the conservative treatment of choice in the lymphedema patients. This method enables effective treatment even in patients with difficult and complicated lymphedema. We present a case of a young man with a massive, primary right lower limb lymphedema, effectively treated with the DLT.
Abstract
The decongestive lymphatic therapy is recommended by the International Society of Lymphology, the International Union of Phlebology and the International Lymphoedema Framework as the conservative treatment of choice in the lymphedema patients. This method enables effective treatment even in patients with difficult and complicated lymphedema. We present a case of a young man with a massive, primary right lower limb lymphedema, effectively treated with the DLT.
Keywords
decongestive lymphatic therapy, lymphedema, bandaging, garments, manual lymphatic drainage
About this articleTitle
The decongestive lymphatic therapy in the massive primary lower limb lymphedema treatment
Journal
Issue
Article type
Case report
Pages
130-134
Published online
2017-09-28
Page views
1098
Article views/downloads
3418
DOI
10.5603/AA.2017.0011
Bibliographic record
Acta Angiologica 2017;23(3):130-134.
Keywords
decongestive lymphatic therapy
lymphedema
bandaging
garments
manual lymphatic drainage
Authors
Katarzyna Drozdz
Angelika Chachaj
Andrzej Szuba
References (14)- Lee BB, Antignani PL, Baroncelli TA, et al. IUA-ISVI consensus for diagnosis guideline of chronic lymphedema of the limbs. Int Angiol. 2015; 34(4): 311–332.
- Moffatt C, Partsch H, Schuren J, et al. Compression Therapy. A position document on compression bandaging. The International Lymphoedema Framework’s. 2012.
- Lamprou DAA, Damstra RJ, Partsch H. Prospective, randomized, controlled trial comparing a new two-component compression system with inelastic multicomponent compression bandages in the treatment of leg lymphedema. Dermatol Surg. 2011; 37(7): 985–991.
- Stout N, Partsch H, Szolnoky G, et al. Chronic edema of the lower extremities: international consensus recommendations for compression therapy clinical research trials. Int Angiol. 2012; 31(4): 316–329.
- Partsch H, Stout N, Forner-Cordero I, et al. Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema (BCRL). Proposals from an expert group. Int Angiol. 2010; 29(5): 442–453.
- Damstra RJ, Partsch H. Compression therapy in breast cancer-related lymphedema: A randomized, controlled comparative study of relation between volume and interface pressure changes. J Vasc Surg. 2009; 49(5): 1256–1263.
- Hampton S, Gray S. Selecting a compression wrap when treating lymphoedema. Br J Community Nurs. 2016; 21(Suppl 10): S37–S39.
- Partsch H, Damstra RJ, Mosti G. Dose finding for an optimal compression pressure to reduce chronic edema of the extremities. Int Angiol. 2011; 30(6): 527–533.
- Feldman JL, Stout NL, Wanchai A, et al. Intermittent pneumatic compression therapy: a systematic review. Lymphology. 2012; 45(1): 13–25.
- Gloviczki P. Principles of surgical treatment of chronic lymphoedema. Int Angiol. 1999; 18(1): 42–46.
- Becker C. Autologous lymph node transfers. J Reconstr Microsurg. 2016; 32(1): 28–33.
- Lee BB, Kim YW, Kim DI, et al. Supplemental surgical treatment to end stage (stage IV-V) of chronic lymphedema. Int Angiol. 2008; 27(5): 389–395.
- Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer. 2002; 95(11): 2260–2267.
- Szuba A, Cooke JP, Yousuf S, et al. Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med. 2000; 109(4): 296–300.